Home Tags AveXis

Tag: AveXis

Dispensed: Venture-backed insurance startup Bright Health’s 2018 results, a dispute between 2 drug giants, and the quest for a male birth contro...

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 ...

A one-time treatment for a devastating rare disease could be paid for with an installment plan in Massachusetts. That could set a roadmap for the US.
Novartis CEO Vas Narasimhan

Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases

Novartis is acquiring gene therapy company AveXis for $8.7 billion. It's part of a wave of big bets in gene therapy, a cutting-edge area of science that has had some big advancements over the past year.